The scientific community understands that a paradigm shift in the treatment of infectious diseases is necessary to prevent antibiotics becoming obsolete, and where appropriate, alternatives to antibiotics should be considered.
Alternative therapies are viewed favourably by many patients because they are often not being helped by conventional therapy and they believe there are fewer detrimental side effects. In addition, many report significant improvement while taking complementary and alternative medicines.
As we approach the ‘post-antibiotic’ era a wealth of research now supports long-held beliefs that Melaleuca Alternifolia has antimicrobial and anti-inflammatory properties.
Below is a list of prominent researchers who are leading the way in providing the clinical evidence demonstrating efficacy against bacterial, fungal, or viral infections – as well as specific cancers.
- Professor Max Reynolds: Director of Griffith University’s Program for Australasia Botanical Medicine for Population Health (Ret), and Managing Director of 98 Alive Pty Ltd.
- Professor Thomas Riley: University of Western Australia Queen Elizabeth II Centre
- Dr. Alex Hyatt, BSc (Hons), dipEd, Ph.D.: Senior Principal Research Scientist, Project leader ‘Bio-imaging’ and Ecohealth’, CISRO, Geelong
- Professor Nasronudin: Airlangga University, Indonesia
- Professor Cordia Chu: Griffith University, Biotech Department (Qld, Australia)
- Chief Doctor, Deng Ganquiang: Centre of Disease Control, Zhejiang Province, (China)
- Deputy Section Director, Wu Pinggu: Centre of Disease Control, Zhejiang Province, (China)
- Director Professor Zhang Yanjun: Centre of Disease Control, Zhejiang Province, (China)
- Carol Lackman-Smith: Infectious Disease Department, Southern Research Institute, (Maryland, USA)
- Professor Lifang Jiang, MD: Director of department of Microbiology at the Zhongshan School of Medicine, Sun Yat-sen University, (China)
- Professor Steve Ralph: Griffith University Medical Centre, (Qld, Australia)
- Professor Lukman Hakim MSc. PhD: Head of the laboratory of Pharmacology and Toxicology, Department of Pharmacology and Clinical pharmacy – Gadjah Mada University (Yogyakarta, Indonesia)
Research and Testing Centres
98 Alive Pty Ltd is committed to rigorously testing and researching 98alive™ in order to discover and harness all of its health and medical benefits and uses. Please find below all research centres and universities that have completed approved clinical trials and research on 98alive™.
- Griffith University – Immune Support Study
- University of Western Australia – Transdermal Patch Study
- Queensland Pathology – Antibiotic Resistant Bacterial Strain Study
- Fire Fox Laboratories – Toxicity Studies
- CSIRO – Geelong, Victoria
- Sun Yat-sen University
- Chinese Centre for Disease
- National Cheng Kung University
- Southern Research Organisation – USA
- Brunswick Laboratories – Antioxidant Testing – USA
- ATS Laboratories – USA
- Gadjah Mada University
- Airlangga University
Melaleuca Research Website: